These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6146074)

  • 1. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 2. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 3. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalidixic-acid resistant Shigella dysenteriae type 1 in eastern India.
    Sen D; Dutta P; Deb BC; Pal SC
    Lancet; 1988 Oct; 2(8616):911. PubMed ID: 2902361
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiresistant Shigella infections in Bangladesh.
    Bennish M; Eusof A; Kay B; Wierzba T
    Lancet; 1985 Aug; 2(8452):441. PubMed ID: 2863461
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
    Datta P; Sen D
    Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia.
    Ashraf MM; Ahmed ZU; Sack DA
    Can J Microbiol; 1991 Jan; 37(1):59-63. PubMed ID: 2021898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
    Munshi MH; Sack DA; Haider K; Ahmed ZU; Rahaman MM; Morshed MG
    Lancet; 1987 Aug; 2(8556):419-21. PubMed ID: 2887725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
    Engels D; Madaras T; Nyandwi S; Murray J
    Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of bacillary dysentery caused by quinolone-resistant Shigella dysenteriae type 1 in a northeastern state of India.
    Niyogi SK; Sarkar K; Lalmalsawma P; Pallai N; Bhattacharya SK
    J Health Popul Nutr; 2004 Mar; 22(1):97. PubMed ID: 15190817
    [No Abstract]   [Full Text] [Related]  

  • 17. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
    Paquet C; Leborgne P; Sasse A; Varaine F
    Sante; 1995; 5(3):181-4. PubMed ID: 7640901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in multiresistance of Shigella dysenteriae type 1 strain in Rwanda.
    Mutwewingabo A; Mets T
    East Afr Med J; 1987 Dec; 64(12):812-5. PubMed ID: 3333152
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutator plasmid in a nalidixic acid-resistant strain of Shigella dysenteriae type 1.
    Ambler JE; Drabu YJ; Blakemore PH; Pinney RJ
    J Antimicrob Chemother; 1993 Jun; 31(6):831-9. PubMed ID: 8360123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.